Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q1 2024 · 10-Q
Revenue$13.26M$13.26M+13.3% vs Q1 2023 Net Income$30.95M$30.95M−10.3% vs Q1 2023 EPS Diluted$0.71$0.71−10.1% vs Q1 2023 Operating Cash Flow$40,827,000+31.5% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 6, 2024 · 36 d after period end